Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 451906, 10 pages
http://dx.doi.org/10.1155/2014/451906
Review Article

The Multiple Roles of EG-VEGF/PROK1 in Normal and Pathological Placental Angiogenesis

1Commissariat à l’Energie Atomique (CEA), DSV-iRTSV, 17 rue des Martyrs, 38054 Grenoble Cedex 9, France
2Université Grenoble-Alpes, 38041 Grenoble, France
3Institut National de la Santé et de la Recherche Médicale U1036 (INSERM U1036), Biologie du Cancer et de l’Infection, Laboratoire BCI-iRTSV, CEA Grenoble, 17 rue des Martyrs, 38054 Grenoble Cedex 9, France
4CHU de Grenoble, Hôpital Couple Enfant, Département de Génétique et Procréation, Centre d’Aide Médicale à la Procréation, CS 10217, 38043 Grenoble Cedex 9, France
5Service de Gynécologie-Obstétrique “C”, Centre Hospitalier Universitaire Ibn Rochd, Faculté de Médecine et de Pharmacie, Université Hassan II, Ain Chok, 1 rue des Hôpitaux-ex Banaflous, 20360 Casablanca, Morocco
6Plateau Commun de Recherche, Unité de Culture Cellulaire, Faculté de Médecine et de Pharmacie, 19 rue Tarek Bnou Ziad, 20360 Casablanca, Morocco
7Centre National de la Recherche Scientifique, UMR 5249, 38054 Grenoble Cedex 9, France

Received 6 February 2014; Revised 8 April 2014; Accepted 14 April 2014; Published 15 May 2014

Academic Editor: Padma Murthi

Copyright © 2014 Nadia Alfaidy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Burton and E. Jauniaux, “Sonographic, stereological and Doppler flow velocimetric assessments of placental maturity,” British Journal of Obstetrics and Gynaecology, vol. 102, no. 10, pp. 818–825, 1995. View at Google Scholar · View at Scopus
  2. M. R. Jackson, T. M. Mayhew, and P. A. Boyd, “Quantitative description of the elaboration and maturation of villi from 10 weeks of gestation to term,” Placenta, vol. 13, no. 4, pp. 357–370, 1992. View at Google Scholar · View at Scopus
  3. D. S. Charnock-Jones, P. Kaufmann, and T. M. Mayhew, “Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation,” Placenta, vol. 25, no. 2-3, pp. 103–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kaufmann, T. M. Mayhew, and D. S. Charnock-Jones, “Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy,” Placenta, vol. 25, no. 2-3, pp. 114–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Benirschke and P. Kaufmann, Pathology of the Human Placenta, Springer, New Tork, NY, USA, 4th edition, 2000.
  6. M. Dellian, B. P. Witwer, H. A. Salehi, F. Yuan, and R. K. Jain, “Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment,” American Journal of Pathology, vol. 149, no. 1, pp. 59–71, 1996. View at Google Scholar · View at Scopus
  7. G. E. Palade, M. Simionescu, and N. Simionescu, “Structural aspects of the permeability of the microvascular endothelium,” Acta Physiologica Scandinavica, vol. 106, no. 463, pp. 11–32, 1979. View at Google Scholar · View at Scopus
  8. W. G. Roberts, J. Delaat, M. Nagane, S. Huang, W. K. Cavenee, and G. E. Palade, “Host microvasculature influence on tumor vascular morphology and endothelial gene expression,” The American Journal of Pathology, vol. 153, no. 4, pp. 1239–1248, 1998. View at Google Scholar · View at Scopus
  9. P. A. Stewart and M. J. Wiley, “Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras,” Developmental Biology, vol. 84, no. 1, pp. 183–192, 1981. View at Google Scholar · View at Scopus
  10. J. Lecouter, J. Kowalski, J. Foster et al., “Identification of an angiogenic mitogen selective for endocrine gland endothelium,” Nature, vol. 412, no. 6850, pp. 877–884, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. C. Lin, C. M. Bullock, F. J. Ehlert, J. L. Chen, H. Tian, and Q. Y. Zhou, “Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor,” Journal of Biological Chemistry, vol. 277, no. 22, pp. 19276–19280, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Urayama, D. B. Dedeoglu, C. Guilini et al., “Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage,” Cardiovascular Research, vol. 81, no. 1, pp. 28–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Urayama, C. Guilini, N. Messaddeq et al., “The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis,” The FASEB Journal, vol. 21, no. 11, pp. 2980–2993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Guilini, K. Urayama, G. Turkeri et al., “Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 3, pp. H844–H852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kisliouk, N. Levy, A. Hurwitz, and R. Meidan, “Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3700–3707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kisliouk, H. Podlovni, and R. Meidan, “Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum,” Annals of Anatomy, vol. 187, no. 5-6, pp. 529–537, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. D. Catalano, T. R. M. Lannagan, M. Gorowiec, F. C. Denison, J. E. Norman, and H. N. Jabbour, “Prokineticins: novel mediators of inflammatory and contractile pathways at parturition?” Molecular Human Reproduction, vol. 16, no. 5, pp. 311–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Kisliouk, H. Podlovni, K. Spanel-Borowski, O. Ovadia, Q. Y. Zhou, and R. Meidan, “Prokineticins (endocrine gland-VEGF and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum derived-endothelial cells,” Endocrinology, vol. 146, no. 9, pp. 3950–3958, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. LeCouter and N. Ferrara, “EG-VEGF and the concept of tissue-specific angiogenic growth factors,” Seminars in Cell and Developmental Biology, vol. 13, no. 1, pp. 3–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Lin, J. LeCouter, J. Kowalski, and N. Ferrara, “Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells,” Journal of Biological Chemistry, vol. 277, no. 10, pp. 8724–8729, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Brouillet, P. Hoffmann, M. Benharouga et al., “Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells,” Molecular Biology of the Cell, vol. 21, no. 16, pp. 2832–2843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Hoffmann, J.-J. Feige, and N. Alfaidy, “Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy,” Endocrinology, vol. 147, no. 4, pp. 1675–1684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Hoffmann, Y. Saoudi, M. Benharouga et al., “Role of EG-VEGF in human placentation: physiological and pathological implications,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8 B, pp. 2224–2235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. C. Denison, S. Battersby, A. E. King, M. Szuber, and H. N. Jabbour, “Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta,” Endocrinology, vol. 149, no. 7, pp. 3470–3477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Matjila, R. Millar, Z. van der Spuy, and A. Katz, “The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development,” PLoS ONE, vol. 8, no. 5, Article ID e63574, 2013. View at Google Scholar
  26. J. Evans, R. D. Catalano, K. Morgan, H. O. D. Critchley, R. P. Millar, and H. N. Jabbour, “Prokineticin 1 signaling and gene regulation in early human pregnancy,” Endocrinology, vol. 149, no. 6, pp. 2877–2887, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Brouillet, P. Murthi, P. Hoffmann et al., “EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR),” Cellular and Molecular Life Sciences, vol. 70, no. 3, pp. 511–525, 2013. View at Publisher · View at Google Scholar
  28. E. Jauniaux, J. Hempstock, N. Greenwold, and G. J. Burton, “Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies,” The American Journal of Pathology, vol. 162, no. 1, pp. 115–125, 2003. View at Google Scholar · View at Scopus
  29. G. J. Burton and E. Jauniaux, “Placental oxidative stress: from miscarriage to preeclampsia,” Journal of the Society for Gynecologic Investigation, vol. 11, no. 6, pp. 342–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. B. R. Zetter, “The endothelial cells of large and small blood vessels,” Diabetes, vol. 30, no. 2, pp. 24–28, 1981. View at Google Scholar · View at Scopus
  31. L. F. Fajardo, “Special report. The complexity of endothelial cells. A review,” The American Journal of Clinical Pathology, vol. 92, no. 2, pp. 241–250, 1989. View at Google Scholar · View at Scopus
  32. R. Bicknell, “Heterogeneity of the endothelial cell,” Behring Institute Mitteilungen, no. 92, pp. 1–7, 1993. View at Google Scholar · View at Scopus
  33. I. Lang, C. Hoffmann, H. Olip et al., “Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity,” Cell Proliferation, vol. 34, no. 3, pp. 143–155, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Lang, M. A. Pabst, U. Hiden et al., “Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells,” European Journal of Cell Biology, vol. 82, no. 4, pp. 163–173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Lang, M. Hartmann, A. Blaschitz, G. Dohr, G. Skofitsch, and G. Desoye, “Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta,” Cell and Tissue Research, vol. 274, no. 2, pp. 211–218, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. J. C. Challier, A. Kacemi, and G. Olive, “Mixed culture of pericytes and endothelial cells from fetal microvessels of the human placenta,” Cellular and Molecular Biology, vol. 41, no. 2, pp. 233–241, 1995. View at Google Scholar · View at Scopus
  37. A. Kacemi, M. Galtier, M. J. Espié, and J. C. Challier, “Isolation of villous microvessels from the human placenta,” Comptes Rendus de l'Académie des Sciences III, vol. 320, no. 2, pp. 171–177, 1997. View at Publisher · View at Google Scholar
  38. B. Ugele and F. Lange, “Isolation of endothelial cells from human placental microvessels: effect of different proteolytic enzymes on releasing endothelial cells from villous tissue,” In Vitro Cellular & Developmental Biology, vol. 37, no. 7, pp. 408–413, 2001. View at Google Scholar
  39. X. Wang, N. Athayde, and B. Trudinger, “A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency,” The American Journal of Obstetrics and Gynecology, vol. 189, no. 5, pp. 1445–1451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. F. Dye, S. Vause, T. Johnston et al., “Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells,” The FASEB Journal, vol. 18, no. 1, pp. 125–127, 2004. View at Google Scholar · View at Scopus
  41. P. Murthi, M. So, N. M. Gude, V. L. Doherty, S. P. Brennecke, and B. Kalionis, “Homeobox genes are differentially expressed in macrovascular human umbilical vein endothelial cells and microvascular placental endothelial cells,” Placenta, vol. 28, no. 2-3, pp. 219–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. D. Murray, “On the mechanochemical theory of biological pattern formation with application to vasculogenesis,” Comptes Rendus—Biologies, vol. 326, no. 2, pp. 239–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. G. E. Davis and D. R. Senger, “Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization,” Circulation Research, vol. 97, no. 11, pp. 1093–1107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Donovan, N. J. Brown, E. T. Bishop, and C. E. Lewis, “Comparison of three in vitro human “angiogenesis” assays with capillaries formed in vivo,” Angiogenesis, vol. 4, no. 2, pp. 113–121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. L. G. Rodriguez, X. Wu, and J. L. Guan, “Wound-healing assay,” Methods in Molecular Biology, vol. 294, pp. 23–29, 2005. View at Google Scholar · View at Scopus
  46. R. K. Miller, O. Genbacev, M. A. Turner, J. D. Aplin, I. Caniggia, and B. Huppertz, “Human placental explants in culture: approaches and assessments,” Placenta, vol. 26, no. 6, pp. 439–448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. O. Genbacev, Y. Zhou, J. W. Ludlow, and S. J. Fisher, “Regulation of human placental development by oxygen tension,” Science, vol. 277, no. 5332, pp. 1669–1672, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. G. J. Burton, E. Jauniaux, and A. L. Watson, “Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd Collection revisited,” The American Journal of Obstetrics and Gynecology, vol. 181, no. 3, pp. 718–724, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Zygmunt, F. Herr, S. Keller-Schoenwetter et al., “Characterization of human chorionic gonadotropin as a novel angiogenic factor,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 5290–5296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Islami, P. Bischof, and D. Chardonnens, “Modulation of placental vascular endothelial growth factor by leptin and hCG,” Molecular Human Reproduction, vol. 9, no. 7-8, pp. 395–398, 2003. View at Google Scholar · View at Scopus
  51. S. Brouillet, P. Hoffmann, S. Chauvet et al., “Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors,” Cellular and Molecular Life Sciences, vol. 69, no. 9, pp. 1537–1550, 2012. View at Google Scholar · View at Scopus
  52. F. Herr, N. Baal, K. Reisinger et al., “HCG in the regulation of placental angiogenesis. Results of an in vitro study,” Placenta, vol. 28, supplement 1, pp. S85–S93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Sa, G. Murugesan, M. Jaye, Y. Ivashchenko, and P. L. Fox, “Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells,” Journal of Biological Chemistry, vol. 270, no. 5, pp. 2360–2366, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Matsumoto, I. Turesson, M. Book, P. Gerwins, and L. Claesson-Welsh, “p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis,” Journal of Cell Biology, vol. 156, no. 1, pp. 149–160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Kuida and D. M. Boucher, “Functions of MAP kinases: Insights from gene-targeting studies,” Journal of Biochemistry, vol. 135, no. 6, pp. 653–656, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Karar and A. Maity, “PI3K/AKT/mTOR Pathway in Angiogenesis,” Frontiers in Molecular Neuroscience, vol. 4, article 51, 2011. View at Publisher · View at Google Scholar
  57. K. Wang and J. Zheng, “Signaling regulation of fetoplacental angiogenesis,” Journal of Endocrinology, vol. 212, no. 3, pp. 243–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. U. A. Kayisli, R. Demir, G. Erguler, and A. Arici, “Vasodilator-stimulated phosphoprotein expression and its cytokine-mediated regulation in vasculogenesis during human placental development,” Molecular Human Reproduction, vol. 8, no. 11, pp. 1023–1030, 2002. View at Google Scholar · View at Scopus
  59. S. Saito, T. Kasahara, S. Sakakura, H. Umekage, N. Harada, and M. Ichijo, “Detection and localization of interleukin-8 mRNA and protein in human placenta and decidual tissues,” Journal of Reproductive Immunology, vol. 27, no. 3, pp. 161–172, 1994. View at Publisher · View at Google Scholar · View at Scopus
  60. I. G. Colditz, “Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8,” Immunology and Cell Biology, vol. 68, no. 6, pp. 397–403, 1990. View at Google Scholar · View at Scopus
  61. K. S. Kim, V. Rajagopal, C. Gonsalves, C. Johnson, and V. K. Kalra, “A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells,” Journal of Immunology, vol. 177, no. 10, pp. 7211–7224, 2006. View at Google Scholar · View at Scopus
  62. R. S. Bowen, Y. Gu, Y. Zhang, D. F. Lewis, and Y. Wang, “Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies,” Journal of the Society for Gynecologic Investigation, vol. 12, no. 6, pp. 428–432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. M. J. Cross, J. Dixelius, T. Matsumoto, and L. Claesson-Welsh, “VEGF-receptor signal transduction,” Trends in Biochemical Sciences, vol. 28, no. 9, pp. 488–494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Brouillet, P. Hoffmann, J. J. Feige, and N. Alfaidy, “EG-VEGF: a key endocrine factor in placental development,” Trends in Endocrinology and Metabolism, vol. 23, no. 10, pp. 501–508, 2012. View at Publisher · View at Google Scholar
  65. S. Brouillet, P. Hoffmann, C. Thomas-Cadi et al., “PROK1, prognostic marker of embryo implantation?” Gynécologie Obstétrique & Fertilité, vol. 41, no. 9, pp. 562–565, 2013. View at Publisher · View at Google Scholar
  66. M. T. Su, S. H. L., Y. C. Chen, L. W. Wu, and P. L. Kuo, “Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy,” Reproduction, vol. 146, no. 1, pp. 63–73, 2013. View at Publisher · View at Google Scholar
  67. M. T. Su, S. H. Lin, I. W. Lee et al., “Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss,” Human Reproduction, vol. 25, no. 11, pp. 2923–2930, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Salker, G. Teklenburg, M. Molokhia et al., “Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss,” PLoS ONE, vol. 5, no. 4, Article ID e10287, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Vuorela, O. Carpén, M. Tulppala, and E. Halmesmäki, “VEGF, its receptors and the Tie receptors in recurrent miscarriage,” Molecular Human Reproduction, vol. 6, no. 3, pp. 276–282, 2000. View at Google Scholar · View at Scopus
  70. M. Zygmunt, F. Herr, K. Münstedt, U. Lang, and O. D. Liang, “Angiogenesis and vasculogenesis in pregnancy,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 110, supplement 1, pp. S10–S18, 2003. View at Publisher · View at Google Scholar
  71. M. M. Manolea, O. A. Gavrilă, F. C. Popescu, L. Novac, and G. O. Mateescu, “The importance of immunohistochemical evaluation of the vascular changes from the decidua and placenta in recurrent pregnancy loss,” Romanian Journal of Morphology and Embryology, vol. 53, no. 2, pp. 363–368, 2012. View at Google Scholar
  72. H. Boufettal, J. J. Feige, M. Benharouga et al., “Potential role of the angiogenic factor, “EG-VEGF” in gestational trophoblastic diseases,” Pathologie Biologie, vol. 61, no. 5, pp. 178–183, 2013. View at Publisher · View at Google Scholar
  73. F. Bolat, N. Haberal, N. Tunali, E. Aslan, N. Bal, and I. Tuncer, “Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1α), and transforming growth factors β1 (TGFβ1) and β3 (TGFβ3) in gestational trophoblastic disease,” Pathology Research and Practice, vol. 206, no. 1, pp. 19–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. Z. S. Tuncer, G. L. Vegh, V. Fulop, D. R. Genest, S. C. Mok, and R. S. Berkowitz, “Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor,” Gynecologic Oncology, vol. 77, no. 3, pp. 389–393, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Szuber, W. Markwitz, M. Ropacka, and G. H. Breborowicz, “The possible role of the PK1 and its receptor in the etiology of the preeclampsia,” Neuroendocrinology Letters, vol. 32, no. 4, pp. 563–572, 2011. View at Google Scholar · View at Scopus
  76. WHO, World Health Report: Make Every Mother and Child Count, World Health Organization, Geneva, Switzerland, 2005.
  77. B. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” The Lancet, vol. 365, no. 9461, pp. 785–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. W. Meekins, R. Pijnenborg, M. Hanssens, I. R. McFadyen, and A. Van Asshe, “A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies,” British Journal of Obstetrics and Gynaecology, vol. 101, no. 8, pp. 669–674, 1994. View at Google Scholar · View at Scopus
  79. R. J. Levine, S. E. Maynard, C. Qian et al., “Circulating angiogenic factors and the risk of preeclampsia,” The New England Journal of Medicine, vol. 350, no. 7, pp. 672–683, 2004. View at Publisher · View at Google Scholar
  80. L. A. Cole, “New discoveries on the biology and detection of human chorionic gonadotropin,” Reproductive Biology and Endocrinology, vol. 7, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. D. F. Liu, L. H. Dickerman, and R. W. Redline, “Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels,” The American Journal of Clinical Pathology, vol. 111, no. 2, pp. 209–215, 1999. View at Google Scholar · View at Scopus
  82. R. Douglas Wilson, A. Gagnon et al., “Obstetrical complications associated with abnormal maternal serum markers analytes,” Journal of Obstetrics & Gynaecology, vol. 30, no. 10, pp. 918–949, 2008. View at Google Scholar
  83. L. A. Cole, “hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation,” Journal of reproductive immunology, vol. 82, no. 2, pp. 112–118, 2009. View at Google Scholar · View at Scopus
  84. J. Kingdom, B. Huppertz, G. Seaward, and P. Kaufmann, “Development of the placental villous tree and its consequences for fetal growth,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 92, no. 1, pp. 35–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. I. Cetin, J. M. Foidart, M. Miozzo et al., “Fetal growth restriction: a workshop report,” Placenta, vol. 25, no. 8-9, pp. 753–757, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Y. Khong, F. De Wolf, W. B. Robertson, and I. Brosens, “Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants,” British Journal of Obstetrics and Gynaecology, vol. 93, no. 10, pp. 1049–1059, 1986. View at Google Scholar · View at Scopus
  87. Y. Zhou, C. H. Damsky, and S. J. Fisher, “Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome?” Journal of Clinical Investigation, vol. 99, no. 9, pp. 2152–2164, 1997. View at Google Scholar · View at Scopus
  88. B. Fitzgerald, K. Levytska, J. Kingdom, M. Walker, D. Baczyk, and S. Keating, “Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A,” Placenta, vol. 32, no. 4, pp. 339–345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Krantz, L. Goetzl, J. L. Simpson et al., “Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes,” The American Journal of Obstetrics and Gynecology, vol. 191, no. 4, pp. 1452–1458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Todros, A. Sciarrone, E. Piccoli, C. Guiot, P. Kaufmann, and J. Kingdom, “Umbilical doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction,” Obstetrics and Gynecology, vol. 93, no. 4, pp. 499–503, 1999. View at Google Scholar · View at Scopus